Hyperhomocysteinemia: a novel risk factor for erectile dysfunction.

Area of Science:

• Cardiovascular Science
• Urology
• Endocrinology

Background:

• Nitric oxide (NO) is crucial for endothelial function, synthesized by NO synthase (NOS).
• Hyperhomocysteinemia, elevated homocysteine (Hcys) levels, is increasingly recognized as a regulator of NOS and a risk factor for endothelial dysfunction.
• Erectile dysfunction (ED) is often associated with impaired NO generation and endothelial dysfunction.

Purpose of the Study:

• To investigate the role of homocysteine (Hcys) in erectile dysfunction (ED) among nondiabetic patients.
• To determine the correlation between Hcys levels and erectile function, as well as vascular parameters in ED patients.

Main Methods:

• A study involving 31 nondiabetic patients with ED and 33 controls, excluding those with diabetes or specific deficiencies.
• Assessment of erectile function using the International Index of Erectile Function (IIEF) questionnaire.
• Measurement of plasma Hcys, glucose, lipids, and vitamin levels, alongside penile color Doppler ultrasound to evaluate vascular function.

Main Results:

• Patients with ED were older and exhibited higher levels of fasting plasma glucose, total cholesterol, LDL cholesterol, and Hcys compared to controls.
• A significant negative correlation was found between mean Hcys levels and mean IIEF domain scores (P < .001).
• Penile Doppler ultrasound revealed a negative correlation between Hcys levels and peak-systolic velocity, indicating arterial dysfunction.

Conclusions:

• Elevated homocysteine (Hcys) levels are a significant determinant of erectile dysfunction (ED) in nondiabetic individuals.
• Hyperhomocysteinemia contributes to ED by causing arterial and endothelial dysfunction, likely through impaired nitric oxide (NO) generation.
• Measuring Hcys levels may be valuable in assessing the risk and underlying mechanisms of ED.